Development of a novel Industrial Air Sanitiser (IAS), to significantly reduce incidence of workers from passing on illnesses (including but not limited to COVID-19) and improve indoor air quality
Development of a novel Industrial Air Sanitiser (IAS), to significantly reduce incidence of workers from passing on illnesses (including but not limited to COVID-19) and improve indoor air quality
批准号:
10004728
负责人:
金额:
$44.57万
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
BPP-Tech brings over 37 years' engineering experience, consistently delivering innovation to its customers.During the COVID-19 pandemic, they developed an Air Mass Sanitiser (AMS) which has the capability to continuously sanitise small indoor air spaces with high-occupancy rates (such as GP surgeries) to destroy SARS-CoV-2 and other pathogens to reduce the risk of infection.Most experts now agree, primary transmission of SARS-CoV-2 (like most respiratory viruses) is through respiratory droplets/airborne viral particles in the air mass, particularly present in crowded/poorly-ventilated spaces. The AMS is now on the brink of commercialisation and will support public-health intervention efforts (vaccination/shielding/track-and-trace) to help the economy return to normal and safeguard against new virus strains and future pandemics.This project will build on this work to develop an 'Industrial-Air-Sanitiser' (IAS), which targets much higher volume spaces (such as factories, large-restaurants, cinemas, museums and indoor farms) to achieve very high-levels of viral kill, targeting both SARS-Cov-2 as well as other problematic viruses (such as avian flu which affects birds and threatens humans through zoonotic mutation) and other unknown virus-strains.The IAS will also be designed for non-pandemic applications aiming to significantly improve Indoor Air Quality (IAQ), which is a significant cause of damage to human health, disease, premature deaths and workplace sickness. Unfortunately, indoor air can be 2-5 times more polluted than outdoor air (due to lack of dilution) meaning if the pollen count or air pollution rate outside is high, it can be significantly worse indoors.Developing the IAS will require significant and radical redesign of the AMS system so it can achieve the requisite air-flow rates for larger indoor spaces. This will involve extensive laboratory testing, computational fluid dynamics (CFD) modelling, prototype building and re-testing to ensure a good design. If successful, this will generate significant revenues for BPP-Tech and lead to significant manufacturing employment (in BPP-Tech and across the supply-chain) in the North East to scale up production to meet demand.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: